1
|
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
|
Ann Intern Med
|
1997
|
3.49
|
2
|
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
|
Hepatology
|
1995
|
2.54
|
3
|
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
|
Hepatology
|
1991
|
2.38
|
4
|
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon.
|
Lancet
|
1991
|
2.14
|
5
|
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
|
Gut
|
2007
|
1.98
|
6
|
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
|
Hepatology
|
2001
|
1.87
|
7
|
Second generation (RIBA) test in diagnosis of chronic hepatitis C.
|
Lancet
|
1991
|
1.84
|
8
|
A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.
|
Hepatology
|
2000
|
1.67
|
9
|
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.
|
Gut
|
2004
|
1.65
|
10
|
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.
|
Gastroenterology
|
1993
|
1.64
|
11
|
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
|
Gut
|
2009
|
1.56
|
12
|
Hepatitis after intravenous buprenorphine misuse in heroin addicts.
|
J Hepatol
|
2001
|
1.51
|
13
|
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
|
Ann Intern Med
|
1997
|
1.44
|
14
|
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
|
J Hepatol
|
1990
|
1.43
|
15
|
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C.
|
J Hepatol
|
2000
|
1.15
|
16
|
Isolation, sequencing and analysis of the expression of Bryonia calmodulin after mechanical perturbation.
|
Plant Mol Biol
|
1993
|
1.13
|
17
|
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.
|
Gut
|
2003
|
1.11
|
18
|
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
|
Hepatology
|
2001
|
1.05
|
19
|
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.
|
Clin Biochem
|
2001
|
1.03
|
20
|
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
|
Hepatology
|
1992
|
1.03
|
21
|
Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg.
|
J Hepatol
|
1997
|
1.00
|
22
|
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
|
J Hepatol
|
1998
|
1.00
|
23
|
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
|
Clin Biochem
|
1999
|
0.98
|
24
|
Treatment of chronic hepatitis B.
|
J Viral Hepat
|
2005
|
0.97
|
25
|
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy.
|
Gut
|
2003
|
0.93
|
26
|
Molecular cloning and characterization of tomato cDNAs encoding glutathione peroxidase-like proteins.
|
Eur J Biochem
|
1998
|
0.92
|
27
|
Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment.
|
J Hepatol
|
2001
|
0.91
|
28
|
Morphological responses and molecular modifications in tomato plants after mechanical stimulation.
|
Plant Cell Physiol
|
1997
|
0.91
|
29
|
Hypocotyl Growth and Peroxidases of Bidens pilosus: EFFECT OF COTYLEDONARY PRICKINGS AND LITHIUM PRETREATMENT.
|
Plant Physiol
|
1981
|
0.88
|
30
|
Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.
|
Liver
|
1994
|
0.87
|
31
|
Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels.
|
J Viral Hepat
|
2002
|
0.86
|
32
|
Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.
|
Clin Exp Immunol
|
2006
|
0.86
|
33
|
[Treatment of chronic hepatitis B].
|
Gastroenterol Clin Biol
|
2008
|
0.85
|
34
|
[Hepatic brucelloma: 2 cases and a review of the literature].
|
Gastroenterol Clin Biol
|
1999
|
0.84
|
35
|
Effects of a mechanical stimulation of localization of annexin-like proteins in Bryonia dioica internodes.
|
Plant Physiol
|
1997
|
0.83
|
36
|
A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C.
|
Liver
|
2000
|
0.83
|
37
|
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.
|
J Viral Hepat
|
2005
|
0.83
|
38
|
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
|
Gastroenterology
|
1995
|
0.83
|
39
|
Specific Inhibition of Lignification in Bryonia dioica: Effects on Thigmomorphogenesis.
|
Plant Physiol
|
1987
|
0.82
|
40
|
[Preliminary evaluation of morbidity due to S. haematobium and S. mansoni in the area of the future Adjarala Dam in Benin].
|
Sante
|
2001
|
0.82
|
41
|
Treatment of hepatitis C patients with normal aminotransferases levels.
|
Clin Liver Dis
|
1999
|
0.81
|
42
|
Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
|
Gut
|
1993
|
0.80
|
43
|
Cytological indication of the involvement of calcium and calcium-related proteins in the early responses of Bryonia dioica to mechanical stimulus.
|
Protoplasma
|
1993
|
0.79
|
44
|
Natural history of hepatitis B.
|
Minerva Gastroenterol Dietol
|
2005
|
0.79
|
45
|
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
|
J Viral Hepat
|
2013
|
0.79
|
46
|
Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.
|
Ann Intern Med
|
1990
|
0.79
|
47
|
Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.
|
J Viral Hepat
|
2006
|
0.79
|
48
|
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.
|
J Hepatol
|
1998
|
0.78
|
49
|
Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C.
|
Ann Intern Med
|
1996
|
0.78
|
50
|
Management of chronic hepatitis C.
|
Minerva Gastroenterol Dietol
|
2007
|
0.78
|
51
|
Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects.
|
Hepatology
|
1990
|
0.78
|
52
|
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
|
Gastroenterol Clin Biol
|
1995
|
0.78
|
53
|
Sequential therapy with adefovir dipivoxil and pegylated interferon alfa-2a for HBeAg-negative patients.
|
J Viral Hepat
|
2010
|
0.76
|
54
|
Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
|
Hepatology
|
1995
|
0.76
|
55
|
Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
|
Liver
|
1995
|
0.76
|
56
|
Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients.
|
Hepatology
|
2000
|
0.76
|
57
|
Re-treatment with interferon alfa of patients with chronic hepatitis C.
|
Hepatology
|
1998
|
0.76
|
58
|
An acute care geriatric unit.
|
Nurs Manage
|
1986
|
0.75
|
59
|
Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
|
Gut
|
1995
|
0.75
|
60
|
Retreatment with interferon-alpha of chronic hepatitis C virus infection.
|
Lancet
|
1994
|
0.75
|
61
|
[Treatment of hepatitis B].
|
Rev Med Interne
|
2002
|
0.75
|
62
|
Changes in plasma membrane fluidity of Bryonia dioica internodes during thigmomorphogenesis.
|
Biochim Biophys Acta
|
1995
|
0.75
|
63
|
Tracking productivity: an easy, quick and useful way.
|
Nurs Manage
|
1986
|
0.75
|
64
|
Interferon-alpha therapy for chronic hepatitis C in special patient populations.
|
Dig Dis Sci
|
1996
|
0.75
|
65
|
Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection.
|
N Engl J Med
|
1989
|
0.75
|
66
|
Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.
|
Minerva Gastroenterol Dietol
|
2006
|
0.75
|
67
|
[Genetic variability of the hepatitis C virus: clinical implications].
|
Gastroenterol Clin Biol
|
2000
|
0.75
|
68
|
Treatment of chronic hepatitis c.
|
Minerva Gastroenterol Dietol
|
2004
|
0.75
|
69
|
Acetylcholinesterase activity changes in medial vestibular complex after hemilabyrinthectomy in the rat.
|
J Vestib Res
|
1996
|
0.75
|
70
|
Tolerability of treatments for viral hepatitis.
|
Drug Saf
|
2001
|
0.75
|
71
|
Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C.
|
J Infect Dis
|
1993
|
0.75
|
72
|
Sequential rooting media and rooting capacity of Sequoiadendron giganteum in vitro. Peroxidase activity as a marker.
|
Plant Cell Rep
|
1987
|
0.75
|